Umbilical Cord-derived Wharton's Jelly Therapy(BioIntegrate)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameUmbilical Cord-derived Wharton's Jelly Therapy(BioIntegrate)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBioIntegrate Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioIntegrate Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A